A central challenge in human genomics is to understand the cellular, evolutionary, and clinical significance of genetic variants. Here we introduce a unified population-genetic and machinelearning model, called Linear Allele-Specific Selection InferencE (LASSIE), for estimating the fitness effects of all potential single-nucleotide variants, based on polymorphism data and predictive genomic features. We applied LASSIE to 51 high-coverage genome sequences annotated with 33 genomic features, and constructed a map of allele-specific selection coefficients across all protein-coding sequences in the human genome. We show that this map is informative about both human evolution and disease.
Introduction
Innovations in DNA sequencing and genotyping have enabled the discovery of millions of genetic variants in human populations, with new variants continuing to be discovered at a rapid pace [1] [2] [3] [4] .
The great majority of these variants, however, are likely to have no impact on cellular function or human phenotypes, including disease, and many others are probably of only minor importance.
The task of identifying which genetic variants are functionally important remains a major ratelimiting step in human genetics, with implications for both basic research and clinical practice.
Numerous computational strategies have been developed for the identification of functional variants, both to prioritize variants for experimental follow-up, and to address broader issues such as the genetic architecture of disease or the fraction of human nucleotides that are functionally important [5] [6] [7] [8] [9] [10] . These computational predictors generally leverage genomic features correlated with function, such as sequence conservation 6, 8, [11] [12] [13] , protein structure [14] [15] [16] , chromatin accessibility 17, 18 , and protein-DNA interactions 19, 20 . Recently it has been shown that predictive power can be boosted by considering multiple features together, typically using supervised machine-learning models such as logistic regression, random forests, or support vector machines [21] [22] [23] [24] [25] . These models detect complex patterns associated with known pathogenic variants and use them to predict the effects of unannotated variants, often with good accuracy.
A separate thread in the population genetics literature has addressed the problem of estimating the bulk distribution of fitness effects (DFE) from a designated collection of genomic regions, such as all coding sequences. Methods for addressing this problem typically calculate the probability of a summary of polymorphism data, such as the site frequency spectrum (SFS), given an explicit parameterization of selection coefficients using diffusion approximations of the WrightFisher model [34] [35] [36] [37] [38] [39] [40] . These methods generally also make use of an explicit model of demographic history, because of the confounding effect of demography on the SFS 36, 37, 41 . These DFE inference methods allow for the inference of true selection coefficients but they are unable to pinpoint the fitness effects of individual variants owing to the intrinsic sparsity of polymorphisms.
In this article, we present a unified model that combines elements of machine-learning methods for variant prediction and diffusion-approximation methods for DFE inference to enable estimation of allele-specific selection coefficients at every nucleotide in a genomic region of interest.
We have implemented our model in a computer program, called Linear Allele-Specific Selection InferencE (LASSIE), and applied it to all protein-coding sequences in the human genome, using publicly available human polymorphism data and more than two dozen predictive genomic features. We validate LASSIE by comparing the estimated selection coefficients with known patterns of natural selection in coding regions and by testing their predictive power for inherited pathogenic variants and cancer-driver mutations. We then show that LASSIE can be used to define a "null" distribution for the relationship between genomic features and selective effects, which enables the identification of genes under unusually strong or unusually weak selection. Genes under unusually strong selection are associated with brain-specific expression and autism spectrum disorder.
Results
LASSIE uses a unified machine-learning and population genetic model to estimate allelespecific selection coefficients. The key idea behind the LASSIE model is that, while polymorphisms are too sparse to allow direct estimation of allele-specific selection coefficients, there is a strong correlative relationship between genomic features and fitness effects that can be exploited to enable such estimation. The general idea is similar to that behind fitCons 9, 28 and LINSIGHT 27 , but in this case a richer machine-learning model accommodates allele-specific effects and a diffusionbased likelihood function allows for the estimation of true selection coefficients.
The LASSIE model consists of two components (Fig. 1) . First, for the population genetic component of the model, we use a generative probabilistic model for the site frequency spectrum (SFS), adopting the Poisson Random Field (PRF) framework for direct likelihood calculations 34, 42, 43 .
Second, we account for predictive genomic features using a neural network. The output of this network is not a class assignment, as in typical supervised-learning applications, but instead is a set of parameters that feed into the PRF model for likelihood calculations. Thus, the overall model is a generative model for the data, fitted in an unsupervised manner by maximization of the likelihood, but it conditions on a potentially large, complex, and informative set of genomic features using a neural network. This conditioning allows for pooling of data across genomic sites, and improved shrinkage estimators for allele-specific selection coefficients.
Population genomic data is described using a PRF-based mixture model. For reasons of efficiency, selection is accommodated using a three-component mixture model rather than a contin-5 uous distribution of selection coefficients. The mixture components capture the average effects of strong negative selection, weak negative selection, and neutral drift, respectively. The use of a mixture model allows the full PRF model to be fitted to the data in a preprocessing step, so that only the site-specific probabilities of the mixture components (the mixture coefficients) need to be estimated in the context of the neural network (see below).
To account for the confounding influence of demography on the SFS, we first fitted a simple demographic model to a collection of putatively neutrally evolving nucleotide sites flanking protein-coding exons. We focused on the 51 high-coverage Yoruba samples from the 1000
Genomes Project, because this population appears to be well described by a pure "expansion"
model, without population bottlenecks or introgression events 34, 37, 39 . We assumed a three-epoch model with a constant effective population size in each epoch, and we estimated the timings and magnitudes of population expansions by maximum likelihood (Methods). The estimated model posits that the Yoruba population experienced a moderate expansion about 6000 years ago, followed by a more dramatic expansion about 600 years ago (Fig. 1b) . Despite its simplicity, this demographic model provides an excellent fit to the observed SFS ( Supplementary Fig. 1 ).
We then fitted a mixture model to genome-wide protein-coding sequence data, estimating the three mixture coefficients as well as the selection coefficients for the weak and strong negative selection components but keeping the neutral model fixed. This analysis indicates that ∼10% of potential coding mutations in the human exome are under weak negative selection with a representative selection coefficient of s = −1.30 × 10 −4 and about 51% of coding mutations are under strong negative selection with a representative selection coefficient of s = −5.86 × 10 −4 (Fig. 1b) .
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We found that this mixture model also fit the exome-wide SFS well ( Supplementary Fig. 1 ).
Genomic features are incorporated using a mixture density network model. We modeled the relationship between genomic features and allele-specific probabilities of selection components using a mixture density network model 44 . This model transforms the genomic features associated with each allele to site-and allele-specific mixture coefficients (Fig. 1c) . These mixture coefficients, in turn, can be used to compute the probability of the exome-wide data under the PRF mixture model. Thus, the edge weights in the neural network function as the free parameters of a generative model for population genomic data conditional on genomic features.
Hypothesizing that genomic features used in variant prioritization would also be informative in this context, we collected 33 diverse features for every potential derived mutation in the human exome, including protein conservation scores, nucleotide conservation scores, protein structural features, RNA-seq signals, and categories indicating changes in the encoded protein (nonsynonymous, nonsense, stop-gained; Fig. 1a ; see Supplementary Table 1 for a complete list of features).
We then fitted the mixture density model to the exome-wide data by maximum likelihood, keeping the selection coefficients fixed at their previously estimated values (see Methods). The features most strongly predictive of selection included stop-gain and missense mutations, several measures of phylogenetic conservation, and several features describing structural properties of amino acid substitutions such as whether the affected reside is buried or exposed, or whether the substitution is predicted to stabilize or destabilize folding 45 ( Supplementary Fig. 2 ). For ease of interpretation, we summarized the probabilities of neutrality, weak negative, and strong negative selection for each candidate mutation by the absolute value of the expected selection coefficient, |s|.
Notice that our general framework allows for a variety of network architectures, ranging from many-layered networks to the simple case of no hidden layers. The use of hidden layers provides the potential to capture nonlinear relationships between genomic features and selection coefficients, but at the cost of larger numbers of free parameters and increased risk of overfitting. In our tests, we found that a linear model actually fit the data better than a nonlinear one (Supplementary Table 2 ), so we have adopted this simple "linear" architecture for LASSIE.
The estimated selection coefficients are consistent with known evolutionary patterns but suggest pervasive weak selection against synonymous mutations. The selection coefficients estimated by LASSIE are highly variable across potential mutations (see Overall, the distribution of |s| recapitulates well-known patterns of constraint on coding sequences. For example, LASSIE predicts that most nonsense mutations are under strong negative selection (Fig. 2c) . In contrast, nonsynonymous mutations show a bimodel distribution of selection coefficients, with modes corresponding to strong and weak negative selection (Fig. 2c) . While coarse-grained and truncated at our estimate for strong negative selection (see Discussion), this distribution is reasonably consistent with the bulk distribution inferred in a non-site-and allele-specific manner in previous studies; for example, we estimate that an expected 45% of nonsynonymous mutations are under neutral or weak negative selection (|s| ≤ 1.3 × 10 −4 in our formulation) in comparison to estimates of ∼30% with |s| ≤ 1.0 × 10 −4 in ref. 37 . In agreement with previous analyses based on codon substitution models 46 , we also find that nonsynonymous mutations in highly expressed genes are under significantly stronger negative selection than nonsynonymous mutations in genes expressed at lower levels (Fig. 2d) .
Interestingly, the distribution of |s| for synynomous mutations suggests that only an expected 70 .5% of such mutations are effectively neutral, whereas 25.9% are under weak negative selection and 3.6% are under strong negative selection (Fig. 2c) . Weak negative selection on synonymous mutations is significantly elevated in highly expressed genes, multi-exon genes, and SRSF1 and SRSF7 binding sites ( Supplementary Fig. 3 ), suggesting that roles in mRNA splicing contribute to it, perhaps among other features. This finding of a substantial influence from weak negative selection on synonymous substitutions is consistent with studies showing reduced substitution rates or reduced nucleotide diversity at synonymous sites relative to pseudogenes or introns [47] [48] [49] [50] [51] [52] and suggests that the widespread practice of using such mutations as a proxy for neutral evolution 49, 53 could result in major biases in downstream analyses (see Discussion).
The estimated selection coefficients are predictive of mutations associated with Mendelian diseases and cancer. While LASSIE was designed as an evolutionary measure, it may also be useful in the prediction of mutations associated with disease, assuming such mutations tend to be under selection 11, 12, 27, 29, 30 . To evaluate the method in this setting, we measured its power in the prediction of known Mendelian disease variants, comparing it with the popular variant prioritiza-tion methods PolyPhen-2 21 , SIFT 11 , Eigen 54 , CADD 29 , and phyloP 8 . In this experiment, we used pathogenic and benign variants from the ClinVar database 55 as positive and negative examples, respectively. Despite no use of disease data for training (see Discussion), LASSIE performed remarkably well on this benchmark (Fig. 3a) , displaying slightly greater values of the area under the receiver operating characteristic curve (AUC) statistic (AUC=0.879) than even the best previously published methods, such as Eigen (AUC=0.867) and PolyPhen-2 (AUC=0.845).
As a second, largely orthogonal, test of predictive power for clinically relevant variants, we evaluated LASSIE's performance in the prioritization of nonsynonymous cancer-driver mutations. Cancer-driver mutations in germline cells may significantly increase the risk of early-onset malignant tumors and, therefore, are likely to be under strong purifying selection in human populations. To test this hypothesis, we obtained a set of nonsynonymous mutations overlapping with mutational hotspots recurrently observed across patients in 243 cancer genes 56 , which should be enriched for cancer drivers. We randomly sampled a matched number of singleton nonsynonymous somatic mutations in the same genes to represent putative passenger mutations. LASSIE showed reasonable accuracy in this task (AUC=0.743), again performing better than all other methods tested, although the overall power was modest for all predictors (Fig. 3b) . Nevertheless, the selection coefficients estimated by LASSIE are significantly predictive of cancer-driver mutations and could potentially be combined with other features to improve predictive power.
To examine disease relevance at higher resolution, we compared our estimates of |s| with a recent saturation genome editing (SGE) study of 13 exons of the BRCA1 gene 57 . This study assigned nearly every possible single nucleotide variant (SNV) in these exons a "function score"
indicating its effect on cell growth in an optimized HAP1 cell line, and then classified each SNV as "non-functional" (i.e., disruptive to growth), "functional" (nondisruptive), or "intermediate."
We found that "non-functional" variants had mostly high estimates of |s|, "functional" variants were enriched for medium and low estimates of |s|, and "intermediate" variants had intermediate estimates of |s| (Fig. 3c) . Moreover, the 20 "pathogenic" variants from ClinVar that have been reviewed by experts almost all were both classified by SGE as "nonfunctional" and had close to the maximum possible estimate of |s|, whereas the 12 expert-reviewed "benign" variants from
ClinVar were almost all "functional" and tended to have low to moderate estimates of |s| (Fig. 3c) .
Indeed, a threshold of |s| = 0.0005 (dotted line) would almost perfectly distinguish between the pathogenic and benign variants in ClinVar, with only three misclassifications (see Supplementary   Fig. 4 for ROC curves). Nevertheless, many "functional" variants appear to be under fairly strong selection, and some "non-functional" variants under fairly weak selection, indicating that there are fundamental limits to the use of natural selection as an indicator for disease (see Discussion).
LASSIE and other methods have reasonable accuracy for rare but not common GWAS variants. Because rare genetic variants are most likely to be under negative selection, we hypothesized that evolution-based methods would be more predictive of rare than common variants associated with complex traits. To evaluate this hypothesis, we tested several methods separately on rare (MAF < 1%) and common (MAF > 5%) nonsynonymous variants from the GWAS catalog 58 , using matched variants from the 1000 Genomes Project as negative controls (Methods). In agreement with our hypothesis, most predictors were significantly more powerful in the prediction of rare GWAS variants than of common variants ( Fig. 3d-e) . Furthermore, LASSIE was among the most accurate methods in the prioritization of both rare and common GWAS variants.
Brain-specific and autism spectrum disorder-related genes are under unusually strong selection. LASSIE's assumption of a single shared relationship, across all genes, between predictive genomic features and |s| may fail for certain subsets of genes. We searched for groups of genes that systematically deviate from this average relationship, using rare variants from 60,706 exomes in the ExAC data set to obtain high-resolution information about strong negative selection 4, 59 . To characterize the "null" distribution for the observed number of nonsynonymous variants per gene, we used a previously estimated context-dependent mutation rate map 60 to describe site-specific mutation rates. This model predicted numbers of rare synonymous variants that were generally well correlated with the observed data ( Supplementary Fig. 5 ). We then combined these sitespecific mutation rates with the probabilities of strong negative selection under LASSIE to obtain an expected rate of rare nonsynonymous variants per each gene. Finally, we computed p-values for the observed numbers of rare (MAF < 0.001) nonsynomous variants per gene with respect to these expected rates under a Poisson-Binomial model (see Methods). We refer to the genes having significantly fewer variants than expected as being under enhanced selection, and the genes with significantly more variants than expected as being under relaxed selection.
Among 11,602 autosomal genes examined, we identified 1,118 genes and 773 genes as being under significantly enhanced or relaxed selection, respectively ( Fig. 4a ; FDR rate < 0.001). Interestingly, we found that the genes under enhanced (strong negative) selection were more likely to be exclusively expressed in the central nervous system (CNS) or associated with autism spectrum disorder 61, 62 (Fig. 4b) . These genes were also enriched in Gene Ontology terms and pathways associated with the CNS 63 (Supplementary Tables 3 & 4) . The genes under relaxed selection, by contrast, tended to be exclusively expressed in liver or skeletal muscle (Fig. 4b) and to be involved in fundamental metabolic pathways (Supplementary Tables 5 & 6 ).
Discussion
In this article, we have introduced LASSIE, the first computational method for estimating allele- For reasons of efficiency, we chose to approximate the full DFE using a mixture model, with components corresponding to neutral drift, weak negative, and strong negative selection. This strategy allows the model to be rapidly fitted to genome-wide data, but results in a rather coarsegrained estimate of the DFE. In our formulation, this approach ignores positive selection, which
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we have previously shown is difficult to detect in this setting 9 . Importantly, this strategy is also limited in its ability to make distinctions among large values of |s|, because estimates are effectively truncated at the value for the "strong" mixture component, |s| = 5.9 × 10 −4 . As a result, LASSIE appears to substantially underestimate |s| for nonsense mutations, for which the true value may be as much as two orders of magnitude larger 64 . A related problem is that our analysis is based on only 51 genome sequences, whereas more precise estimates will depend on much larger data sets (ref. 64 considered >60,000 exomes). In principle, our framework could be extended to infer full continuous distributions of s from larger data sets, but such an extension would require a number of technical improvements, including relaxation of the infinite-sites assumption underlying our model for the site frequency spectrum, accurately accounting for the effects of very recent explosive population growth 4, 65 , and further improvements to computational efficiency.
Strikingly, we find that about 30% of synonymous mutations are under negative selection.
Selection on synonymous mutations appears to be almost exclusively weak, rather than strong, suggesting a limited impact on disease. Nevertheless, weak selection will tend to prohibit the fixation of synonymous alleles and will reduce synonymous substitution rates. Indeed, at a selection coefficient of s = −1.3 × 10 −4 (our estimate for the corresponding mixture component), nearly all selected synonymous mutations would eventually be lost, rather than fixed, causing the observed synonymous substitution rate to be reduced by almost 30% relative to the neutral rate.
This projection is consistent with a number of previous analyses of human and other mammalian data [47] [48] [49] [50] [51] [52] , which have observed reductions of ∼20-40% in substitution rates or nucleotide diversity at synonymous sites. Overall, it appears that negative selection on synonymous mutations is far more common than once believed, even in humans, with important implications for the widespread practice of using synonymous sites to estimate the neutral substitution rate.
The value of evolutionary methods for disease prediction ultimately depends on the degree to which natural selection correlates with disease risk. While many disease-associated variants show signatures of selection, it stands to reason that some will not, for example, because they are associated with late-onset diseases or diseases whose prevalence is strongly associated with features of modern life. Conversely, many potential variants that show signatures of selection will not relate to disease, for example, because they are strongly deleterious at embryonic or even pre-fertilization (e.g., in sperm competition) stages and never appear in patients; because they are deleterious only in the presence of a no-longer-existing genetic background; or because they reduce fitness without disrupting normal health (as through sexual selection). Nevertheless, the relationship between natural selection and Mendelian disease is sufficiently strong that evolutionary methods are fairly effective at identifying pathological variants in databases such as ClinVar, with LASSIE performing as well or better, in our experiments, than any other available computational method-including well-established methods such as PolyPhen-2 and SIFT. Interestingly, LASSIE also significantly outperformed other methods in the prioritization of nonsynonymous cancer-driver mutations, despite not being designed for the unique features of somatic evolution.
We found that recently published measures of the functional impact of point mutations in
BRCA1 based on saturation genome editing (SGE) 57 correlated fairly well with LASSIE's measure of natural selection, both across all mutations and for the subset in ClinVar (Fig. 3c) . Nevertheless, an expected 44% of variants considered "functional" (i.e., non-disrupting) by SGE were estimated by LASSIE to be under strong negative selection and 9% of "non-functional" mutations were estimated to be under only weak selection. These discordances could in part reflect the influence of natural selection in other cell types or conditions, or limitations of the assay as a measure of disease importance. In any case, they suggest-based on this one gene, cell type, and functional assay-that while there is a strong positive correlation between signatures of natural selection and disease impact, there are nevertheless many exceptions to this general correspondence.
While evolutionary methods clearly have value in predicting Mendelian disease variants, it
is less clear that they will be useful for identifying causal variants for complex diseases or other complex traits, many of which segregate at high frequencies, making them unlikely to be under detectable negative selection. Indeed, we found that none of the variant prioritization methods we tested performed well in common variant prediction (Fig. 3e) . Interestingly, however, LASSIE and other evolution-based methods performed much better for rare variants associated with complex traits (Fig. 3d ), presumably because rare variants tend to have larger effect sizes and experience stronger negative selection. Indeed, recent studies have shown that the effect sizes of GWAS variants are negatively correlated with allele frequencies and allele ages 66, 67 . Together, these observations suggest that evolution-based methods may have an under-appreciated potential for the identification of rare variants associated with complex traits.
We were able to obtain reasonable estimates of allele-specific selection coefficients by pooling data across many genes, thereby "shrinking" estimates toward their average values given the genomic features. As in all such shrinkage strategies, however, the decreased variance in the estimates comes at the cost of increased bias, which will be most evident for genes that are atypical 16 in some way. We attempted to turn this limitation into a strength by using it to reveal classes of genes that showed unusually large or small numbers of variants relative to the LASSIE predictions, corresponding to "enhanced" or "relaxed" strong negative selection. Interestingly, we found that genes under "enhanced" selection are enriched for brain-specific expression and an association with autism spectrum disorder (ASD). This observation is consistent with a reported enrichment for likely gene-disrupting de novo mutations in ASD-affected probands relative to unaffected siblings, suggesting the existence of ∼400 ASD-associated genes under particularly strong selection [68] [69] [70] [71] we masked all CpG dinucleotides present in either the reference genome or alternative alleles.
We also obtained the distributions of ancestral alleles in the human-chimp most recent common ancestor from these same previous studies. In this case, we integrated over these distributions when inferring the global demographic model and mixture model for selection, but then conditioned on the most likely ancestral alelle in the mixture density network for simplicity and efficiency.
Demographic model and exome-wide distribution of selection coefficients. To obtain sites largely free from selection, we began with the putatively neutral regions defined for INSIGHT 33, 83 .
Briefly these regions are defined by excluding all coding exons, conserved noncoding elements, and their close flanking regions. We intersected these regions with the 2-kb flanking regions of all coding exons in the Consensus CDS database 84 to obtain a subset of putatively neutral sites proximal to coding exons and therefore approximately matched to them in terms of influence from selection from linked sites. We fitted a three-epoch demographic model to the site-frequency spectrum in these exon-proximal "neutral" regions, using Poisson Random Field (PRF) theory for inference (see Supplementary Note for details).
We then estimated the bulk distribution of selection coefficients in coding regions under a three-component mixture model, with components for neutral evolution (s 0 = 0), weak negative selection (s 1 < 0), and strong negative selection (s 2 < s 1 ). This model is defined by the selection coefficients {s 0 , s 1 , s 2 } and three corresponding mixture coefficients, {w 0 , w 1 , w 2 }, where w i represents the probability that each mutation belongs to component i of the model. The free parameters {s 1 , s 2 , w 0 , w 1 , w 2 } were estimated by maximum likelihood, subject to the constraints that w 0 + w 1 + w 2 = 1, {w 0 , w 1 , w 2 } ≥ 0, with s 0 = 0 held fixed (Supplementary Note).
Training the mixture density model. We trained the mixture density network for inference of allele-specific selection coefficients using mini-batch gradient descent. Data for chromosome 1 was used for testing, data for chromosome 2 was used for validation, and data from the remaining chromosomes was used for training, except for the sex chromosomes (X & Y), which were excluded due to their atypical patterns of mutation and selection, as in previous work. The batch-size was set to 100 nucleotides and the training data were shuffled prior to processing. After each epoch of training, we evaluated the model on the validation set (chromosome 2) and stopped training if the loss (negative log likelihood) did not decrease after five successive epochs (early stopping). Finally, we selected the set of parameters estimated in the epoch with the lowest validation loss. After training, we assigned each potential coding mutation its expected selection coefficient s under the site-and allele-specific distribution defined by the mixture density network, that is, with,
(see Fig. 1c ). By construction, s ≤ 0, so we generally summarize these estimates using |s|, which can be interpreted as a measure of the strength of negative selection. Despite that chromosome X was excluded from the training set, we did generate predictions for this chromosome because it contains many disease variants. For the evaluation of cancer-driver mutations, we obtained pan-cancer somatic mutations and hotspots of nonsynonymous mutations from ref. 56 . We defined cancer genes to be protein-coding genes containing at least one mutational hotspot, cancer-driver mutations to be somatic mutations overlapping mutational hotspots, and passenger mutations to be singleton mutations within cancer genes but not overlapping mutational hotspots. As above, we filtered out all somatic mutations overlapping 1000 Genomes Project variants or the training set of PolyPhen-2, and matched the numbers of cancer diver mutations and passenger mutations by random sampling without replacement.
For the evaluation of nonsynonymous variants associated with complex traits or diseases, we obtained GWAS variants from the GWAS Catalog 58 (downloaded in November 2017) and identified subsets of rare variants (MAF < 0.01) and common variants (MAF > 0.05). We used nonsynonymous variants from the 1000 Genomes Project as negative controls. After observing that the GWAS variants tended to have higher MAFs than these controls, we matched the distributions of MAFs for the two sets and then randomly sampled negative examples matched in both number and MAF to the GWAS variants, repeating the sampling 100 times to quantify uncertainty.
Identification of genes under enhanced or relaxed selection. Our model for the expected rates of ultra-rare (MAF < 0.001) variants in the ExAC data 4 depended critically on an accurate mutation model. Our mutation model was based on precomputed context-dependent mutation rates from the website of the Genome of the Netherlands 60, 86 . Because of differences in sample size, we expected that the local mutation rates in the ExAC data would be proportional, but not equal, to the rates estimated from the Genomes of the Netherlands data. Therefore, to recalibrate the local mutation rates, we fitted a simple logistic regression model for the entire genome based on the numbers of ultra-rare synonymous variants in the ExAC data set, assuming that the impact of natural selection on these variants should be minimal. (Note that our finding that few synonymous mutations are under strong negative selection, Fig. 2b , supports this assumption.) Specifically, the logistic regression assumes,
where p i denotes the probability of observing a rare synonymous mutation i, d i is the sequencing coverage at the corresponding position (which varies considerably in the ExAC data), and µ i is the corresponding mutation rate estimated by the Genomes of the Netherlands. We validated the mutational model by comparing the observed number of synonymous mutations with the expected number predicted by the mutational model for each gene. We removed short genes (with <200 potential synonymous mutations) and genes for which the mutational model seemed to be misspecified (FDR rate ≤ 0.2) from further consideration.
Based on this recalibrated mutation model, we defined a null model for the number of nonsynonymous mutations per gene given the site-and allele-specific selection coefficients estimated by LASSIE. First, we calculated q i , the expected probability of observing a nonsynonymous mutation i, as
where p i is the probability of mutation i under the neutral mutational model, w 2,i is the probability that mutation i is under strong selection as estimated by LASSIE, and h(·) is a mapping from the probabilities of strong selection to relative rates of the nonsynonymous mutation in the ExAC data. To estimate h(·), we grouped all potential nonsynonymous mutations into 1000 equal-width bins based on w 2,i and then estimated h(·) for each selection bin by calculating the ratio of the observed to the expected numbers of nonsynonymous mutations. We then calculated q i for each nonsynonymous mutation i and used q i to parameterize a Poisson-Binomial distribution describing the null distribution of the number of nonsynonymous mutations for each gene. The probability mass function of the Poisson-Binomial model for a single gene is given by,
where k is the observed number of nonsynonymous mutations in the gene and F k is the set of all possible arrangements of k nonsynonymous mutations. Genes under enhanced or relaxed selections were identified by two separate one-tail tests based on this Poisson-Binomial distribution.
Gene enrichment analysis. The enrichment analysis of tissue-specific expression was based on annotated tissue-specific genes from the Human Protein Atlas 61 . Only tissues having more than 50
tissue-specific genes were included. The analysis of autism spectrum disorder (ASD) was based on ASD-related genes from the SFARI Gene database 62 . In both cases, significant enrichments were determined using Fisher's exact test. For the analysis of functional categories, we used PANTHER to investigate the enrichment of both Gene Ontology Slim categories and Reactome pathways 63, 87 .
Code availability. (c) A mixture density network model defines the probabilities of the three components of the mixture model (P neutral , P weak , and P strong ) for each possible mutation at each nucleotide site, conditional on the local genomic features. These probabilities allow the likelihood of the polymorphism data to be computed under the Poisson Random Field (PRF) model, using diffusion approximation methods. The parameters of the network are estimated by maximum likelihood, by treating the (negative) log likelihood as a loss function for the neural network. After training, the weights for the three mixture components define a coarse-grained distribution of fitness effects for all potential mutations at each site. This distribution is summarized by a single expected value of |s| for each mutation. . Each dot represents a single proteincoding gene. Dots for genes showing significantly more rare variants than expected ("relaxed"; n = 773) are colored red, whereas those for genes showing significantly fewer rare variants than expected are colored blue ("enhanced"; n = 1118). (b) Groups of genes enriched for enhanced or relaxed selection. Dots represent odds ratios of enrichment, with bars indicating 95% confidence intervals. Genes under enhanced selection tend to be exclusively expressed in the central nervous system or associated with autism spectrum disorder. In contrast, genes under relaxed selection tend to be exclusively expressed in liver and skeletal muscle.
